- Home
- FULT vs AMRX Comparison
FULT vs AMRX Comparison
Compare FULT & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FULT
- AMRX
- Stock Information
- Founded
- FULT 1882
- AMRX 2002
- Country
- FULT United States
- AMRX United States
- Employees
- FULT N/A
- AMRX N/A
- Industry
- FULT Major Banks
- AMRX Biotechnology: Pharmaceutical Preparations
- Sector
- FULT Finance
- AMRX Health Care
- Exchange
- FULT Nasdaq
- AMRX Nasdaq
- Market Cap
- FULT 3.2B
- AMRX 3.3B
- IPO Year
- FULT N/A
- AMRX N/A
- Fundamental
- Price
- FULT $18.51
- AMRX $10.48
- Analyst Decision
- FULT Hold
- AMRX Strong Buy
- Analyst Count
- FULT 3
- AMRX 4
- Target Price
- FULT $20.67
- AMRX $12.00
- AVG Volume (30 Days)
- FULT 1.4M
- AMRX 1.7M
- Earning Date
- FULT 10-21-2025
- AMRX 10-30-2025
- Dividend Yield
- FULT 3.89%
- AMRX N/A
- EPS Growth
- FULT 1.58
- AMRX N/A
- EPS
- FULT 1.71
- AMRX 0.01
- Revenue
- FULT $1,211,863,000.00
- AMRX $2,852,914,000.00
- Revenue This Year
- FULT N/A
- AMRX $9.52
- Revenue Next Year
- FULT $2.92
- AMRX $6.31
- P/E Ratio
- FULT $10.83
- AMRX $965.99
- Revenue Growth
- FULT 12.50
- AMRX 9.81
- 52 Week Low
- FULT $14.33
- AMRX $6.69
- 52 Week High
- FULT $22.49
- AMRX $10.68
- Technical
- Relative Strength Index (RSI)
- FULT 44.07
- AMRX 64.35
- Support Level
- FULT $18.03
- AMRX $10.35
- Resistance Level
- FULT $18.98
- AMRX $10.61
- Average True Range (ATR)
- FULT 0.37
- AMRX 0.25
- MACD
- FULT -0.05
- AMRX 0.03
- Stochastic Oscillator
- FULT 34.14
- AMRX 74.15
About FULT Fulton Financial Corporation
Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.